Tag: New England Journal of Medicine

  • Nation & World

    What Rochelle Walensky learned

    Sees major progress in science since 1918 Spanish flu outbreak, but says complications of politics have plagued every epidemic since

    5 minutes
    Former CDC director Rochelle Walensky at the podium.
  • Nation & World

    ‘Writing to push conversations forward’

    Simar Singh Bajaj ’24 has had papers published in prestigious journals such as The New England Journal of Medicine and The Lancet.

    3 minutes
    Simar Bajaj ’24, and Fatima Stanford,
  • Nation & World

    The omega-3 fatty acid that may improve heart health

    A high dose of a purified ethyl ester of eicosapentaenoic acid in patients at elevated cardiac risk significantly reduces cardiovascular events.

    2 minutes
    A 3D illustration concept of the human heart
  • Nation & World

    A public-relations campaign to build trust in COVID vaccine?

    A public campaign to build trust may be needed if a successful vaccine candidate is to be taken by enough Americans to interrupt the COVID pandemic, a Harvard public health expert said.

    5 minutes
    Vaccine being held in gloved hands.
  • Nation & World

    Alarming obesity projections for children in U.S.

    If current trends continue, more than 57 percent of U.S. children will be obese at age 35, according to a new study from the Harvard Chan School.

    3 minutes
  • Nation & World

    Precancerous state found in blood

    Harvard researchers have uncovered an easily detectable, “premalignant” state in the blood that significantly increases the likelihood that an individual will go on to develop blood cancers such as leukemia, lymphoma, or myelodysplastic syndrome.

    7 minutes
  • Nation & World

    ‘Bubble boy’ gene therapy raises hope

    A new form of gene therapy for boys with the life-threatening condition known as “bubble boy” disease appears to be both effective and safe, according to an international clinical trial run by a team from Harvard Medical School, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, and other institutions.

    4 minutes
  • Nation & World

    Nut consumption reduces risk of death

    In the largest study of its kind, people who ate a daily handful of nuts were found to be 20 percent less likely to die from any cause over a 30-year period than those who didn’t consume nuts, say Harvard researchers.

    4 minutes
  • Nation & World

    40% prevention rate for colorectal cancers

    A Harvard study has found that 40 percent of all colorectal cancers might be prevented if people underwent regular colonoscopy screenings. The new research also supports existing guidelines that recommend that people with an average risk of colorectal cancer should have a colonoscopy every 10 years.

    3 minutes
  • Nation & World

    Looming malpractice

    The average physician will spend more than 10 percent of his or her career facing an open malpractice claim. Some specialists will spend upwards of 27 percent.

    4 minutes
  • Nation & World

    Aspirin’s impact on colorectal cancer

    Harvard researchers at Dana-Farber Cancer Institute find that aspirin therapy can extend the life of colorectal cancer patients whose tumors carry a mutation in a key gene, but it has no effect on patients who lack the mutation.

    3 minutes
  • Nation & World

    Expanding Medicaid to low-income adults

    A new study from Harvard School of Public Health (HSPH) finds that expanding Medicaid to low-income adults leads to widespread gains in coverage, increased access to care, and — most importantly — improved health and reduced mortality.

    3 minutes
  • Nation & World

    Moving beyond health care’s fee-for-service

    Harvard researchers find that global budgets for health care, an alternative to the traditional fee-for-service model of reimbursement, can slow the growth of medical spending and improve the quality of care for patients.

    5 minutes
  • Nation & World

    Experimental drug improves Cushing’s disease

    A new investigational drug significantly reduced urinary cortisol levels and improved symptoms of Cushing’s disease in the largest clinical study of this endocrine disorder ever conducted.

    5 minutes
  • Nation & World

    Good news for marathoners

    Harvard researchers have found that those participating in marathons and half-marathons are not at an increased risk of cardiac arrest.

    4 minutes
  • Nation & World

    Impact of cutting co-pay on meds

    Researchers from Harvard-affiliated Brigham and Women’s Hospital evaluated whether eliminating co-payments for specific medications following a heart attack would increase adherence and improve outcomes in patients.

    3 minutes
  • Nation & World

    True cost of medical malpractice

    The debates over health care reform may soon become more informed. A new study undertaken by a group of researchers, including Harvard Kennedy School (HKS) Professor Amitabh Chandra, provides a detailed snapshot of U.S. medical malpractice claims, awards, and frequency by specialty.

    2 minutes
  • Nation & World

    Benefits of eating fish tip the scale

    In a new, large-scale study from Harvard School of Public Health and Brigham and Women’s Hospital, researchers found no evidence that higher levels of mercury exposure were associated with higher risk of coronary heart disease, stroke, or total cardiovascular disease in two separate studies of U.S. adults.

    4 minutes
  • Nation & World

    Mixed messages

    A comparative analysis found wide disparities in the results of four common measures of hospital-wide mortality rates, with competing methods yielding both higher- and lower-than-expected rates for the same Massachusetts hospitals during the same year.

    5 minutes
  • Nation & World

    Cholera strain tied to South Asia

    A team of researchers has determined that the strain of cholera erupting in Haiti matches bacterial samples from South Asia and not those from Latin America.

    7 minutes
  • Nation & World

    New drug extends life of melanoma patients

    A therapy that multiplies the effect of a natural disease-fighting antibody has extended the lives of patients with metastatic melanoma in a large, international clinical trial.

    4 minutes
  • Nation & World

    Physician training 2.0

    Doctors at Brigham and Women’s Hospital team up with the New England Journal of Medicine to create online medical cases that can teach better than lectures.

    3 minutes